Clinical manifestations and therapeutic response to recombinant factor VII in patients with glanzmann thrombasthenia

被引：0
|
作者：
Naderi, M. [1 ]
Dorgalaleh, A. [2 ]
Shadi, T. [2 ]
Eshghi, P. [3 ]
Alizadeh, S. [2 ]
Varmaghani, B. [2 ]
Bamedi, T. [4 ]
机构：
[1] Zahedan Univ Med Sci, Zahedan, Iran
[2] Univ Tehran Med Sci, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Pediat Congenital Hematol Disorders Res Ctr, Tehran, Iran
[4] Zahedan Univ Med Sci, Cellular & Mol Res Ctr, Zahedan, Iran
来源：
HAEMOPHILIA | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [1] The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
    Poon, Man-Chiu
    [J]. THROMBOSIS AND HAEMOSTASIS, 2021, 121 (03) : 332 - 340
  • [2] Use of recombinant factor VII in Glanzmann thrombasthenia: A case report
    Ben Abdallah, R. Chabchoub
    Trabelsi, L.
    Ben Ameur, S.
    Kammoun, F.
    Boukedi, A.
    Ben Salah, M.
    Ben Hlima, N.
    Mahfoudh, A.
    [J]. ARCHIVES DE PEDIATRIE, 2010, 17 (07): : 1062 - 1064
  • [3] Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature
    Rajpurkar, M.
    Chitlur, M.
    Recht, M.
    Cooper, D. L.
    [J]. HAEMOPHILIA, 2014, 20 (04) : 464 - 471
  • [4] Successful treatment of Glanzmann's Thrombasthenia with recombinant activated Factor VII "NovoSeven"
    Keikhaei, Bijan
    [J]. HAEMOPHILIA, 2014, 20 : 101 - 102
  • [5] Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a
    Hennewig, U
    Laws, HJ
    Eisert, S
    Göbel, U
    [J]. KLINISCHE PADIATRIE, 2005, 217 (06): : 365 - 370
  • [6] Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia
    Poon, Man-Chiu
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (05) : 655 - 664
  • [7] Use of recombinant factor VIIa (NovoSeven®) in patients with Glanzmann thrombasthenia
    Poon, MC
    d'Oiron, R
    Hann, I
    Négrier, C
    de Lumley, L
    Thomas, A
    Karafoulidou, A
    Demers, C
    Street, A
    Huth-Kühne, A
    Petrini, P
    Fressinaud, E
    Morfini, M
    Tengborn, L
    Marquès-Verdier, A
    Musso, R
    Devecioglu, O
    Houston, DS
    Lethagen, S
    Van Geet, C
    von Depka, M
    Berger, C
    Beurrier, P
    Britton, HA
    Gerrits, W
    Guthner, C
    Kuhle, S
    Lorenzo, JJ
    Makris, PE
    Nohe, N
    Paugy, P
    Pautard, B
    Torchet, MF
    Trillot, N
    Vicariot, M
    Wilde, J
    Winter, M
    Chambost, H
    Ingerslev, J
    Peters, M
    Strauss, G
    [J]. SEMINARS IN HEMATOLOGY, 2001, 38 (04) : 21 - 25
  • [8] Immune gene polymorphisms associated with poor response to platelet transfusion and recombinant factor VII administration in Glanzmann thrombasthenia
    Naderi, Majid
    Mirzaei, Ilia
    Seidizadeh, Omid
    Moud, Abolfazl Parsi
    Sarani, Hosna
    Avan, Amir
    Taheri, Mohsen
    Jahantigh, Danial
    Keramati, Mohammad Reza
    Sohrabi, Tayebeh
    [J]. HAEMOPHILIA, 2024, 30 (03) : 752 - 764
  • [9] Pregnancy in Glanzmann Thrombasthenia using recombinant activated factor VII, a case report and review article
    Baghaipour, M.
    [J]. HAEMOPHILIA, 2008, 14 : 156 - 156
  • [10] Experience of recombinant-activated factor VII to control bleeding in children with Glanzmann’s thrombasthenia
    Khair K.
    Svirin P.
    [J]. Comparative Clinical Pathology, 2007, 16 (3) : 167 - 172
12345